Last week there were a handful of recalls due to the presence of NDEA. Here are the latest.
From lack of sterility to discoloration, here are the latest recalls.
From high concentrations of ibuprofen for infants to a metal shard found in a tablet, here are the latest recalls.
From children’s allergy medicine to antacid tablets containing metal particles, here are the latest recalls.
Cheese as “cancer protection” among other misbrandings last month. See the FDA’s warning letters for food companies in October.
When is a CRO not a CRO? A look at 21 CFR Part 312.
This week the FDA posted 4 new warning letters. One was issued to a cell/tissue product manufacturer, 1 to a firm for failure to list, 1 to a compounding pharmacy, and 1 to a device manufacturer. We cover 3 of these in this post.
From contaminated toothpaste on the shelves to "lack of sterility" across the board, here are last week’s recalls.
This was an exceptionally light week of only 2 published warning letters, 1 of which was a compounding pharmacy which we cover in this post.